Showing results (1311-1320 of 1,431) with videos related to
Sort By:
Pageof 144
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 21, 2023
Symptom screening with Targeted Early Palliative care (STEP) versus usual care for patients with advanced cancer: a mixed methods studyCamilla Zimmermann, Ashley Pope, Breffni Hannon, et al.Breast Cancer Research and Treatment|April 16, 2026
The association of an exercise and rehabilitation clinical workflow algorithm on sedentary behavior and performance status from time of breast cancer diagnosis and throughout careKelsey E Maslana, Ryan D Burns, Yang Bai, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2011
Randomized, double-blind, placebo-controlled phase II study of AMG 386 combined with weekly paclitaxel in patients with recurrent ovarian cancerBeth Y Karlan, Amit M Oza, Gary E Richardson, et al.Nature Reviews. Genetics|July 14, 2005
Facilitating genome navigation: survey sequencing and dense radiation-hybrid gene mappingChristophe Hitte, Jennifer Madeoy, Ewen F Kirkness, et al.Journal of Cardiovascular Electrophysiology|June 16, 2026
Comparative Efficacy of Continuous Versus Patch ECG Monitoring in Detecting Atrial Fibrillation Recurrence Post Catheter Ablation: Insights From the REAL-AF RegistryChinmaya Mareddy, Yashendra Sethi, Gurpreet Johal, et al.The Lancet. Oncology|March 21, 2021
Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trialAndrés Poveda, Anne Floquet, Jonathan A Ledermann, et al.The Lancet. Oncology|March 17, 2022
Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trialRebecca Kristeleit, Alla Lisyanskaya, Alexander Fedenko, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2016
Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: recurrent diseaseM K Wilson, E Pujade-Lauraine, D Aoki, et al.Gynecologic Oncology|October 4, 2021
Characterization of patients with long-term responses to rucaparib treatment in recurrent ovarian cancerElizabeth M Swisher, Rebecca S Kristeleit, Amit M Oza, et al.Cancer|January 9, 2020
Development of the Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator (FACT-ICM): A toxicity subscale to measure quality of life in patients with cancer who are treated with ICMsAaron R Hansen, Kari Ala-Leppilampi, Chris McKillop, et al.Pageof 144